Defining the role of AP1 in molecular adaptation to hypoxia in colorectal cancer

Defining the role of AP1 in molecular adaptation to hypoxia in colorectal cancer

Opis bibliograficzny
Główni autorzy:	Vancauwenberghe, E, Bolland, H, Carroll, C, Da Motta, L, Grabowska, A, Buffa, F, Harris, A, McIntyre, A
Format:	Conference item
Język:	English
Wydane:	American Association for Cancer Research 2019

Podobne zapisy

The tumour hypoxia induced non-coding transcriptome.
od: Choudhry, H, i wsp.
Wydane: (2016)

Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia
od: Haider, S, i wsp.
Wydane: (2016)

The role of hypoxia regulated microRNAs in cancer.
od: McCormick, R, i wsp.
Wydane: (2010)

Gene expression and hypoxia in breast cancer.
od: Favaro, E, i wsp.
Wydane: (2011)

Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis.
od: Jubb, A, i wsp.
Wydane: (2010)

Gene expression signatures as biomarkers of tumour hypoxia
od: Harris, B, i wsp.
Wydane: (2015)

Metabolic and hypoxic adaptation to anti‐angiogenic therapy: a target for induced essentiality
od: Alan McIntyre, i wsp.
Wydane: (2015-02-01)

The prognostic value of hypoxia, proliferation and radiation sensitivity gene signatures: Toward a "molecular treatment planning system"
od: Starmans, M, i wsp.
Wydane: (2006)

In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer
od: Abu-Jamous, B, i wsp.
Wydane: (2017)

Proline-hydroxylated hypoxia-inducible factor 1a (HIF-1a) upregulation in human tumours
od: Snell, C, i wsp.
Wydane: (2014)

Endogenous markers of hypoxia/anaerobic metabolism and anemia in primary colorectal cancer.
od: Koukourakis, M, i wsp.
Wydane: (2006)

Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene.
od: Buffa, F, i wsp.
Wydane: (2010)

The effects of chemotherapy agents on hypoxia in colorectal cancer
od: Siddiky, A
Wydane: (2015)

Disrupting hypoxia-induced bicarbonate transport acidifies tumor cells and suppresses tumor growth
od: McIntyre, A, i wsp.
Wydane: (2016)

Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer
od: Morotti, M, i wsp.
Wydane: (2019)

An Experimentally Defined Hypoxia Gene Signature in Glioblastoma and Its Modulation by Metformin
od: Marta Calvo Tardón, i wsp.
Wydane: (2020-09-01)

The process of adapting an online induction course to support distinct student cohorts
od: Kirsty McIntyre, i wsp.
Wydane: (2022-09-01)

Mild intermittent hypoxia exposure induces metabolic and molecular adaptations in men with obesity
od: Rens L.J. van Meijel, i wsp.
Wydane: (2021-11-01)

Two color imaging of different hypoxia levels in cancer cells
od: Wallabregue, ALD, i wsp.
Wydane: (2023)

Novel hypoxia- and lactate metabolism-related molecular subtyping and prognostic signature for colorectal cancer
od: An Huang, i wsp.
Wydane: (2024-06-01)

The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer (TNBC)
od: Harris, A, i wsp.
Wydane: (2016)

Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia.
od: Koukourakis, M, i wsp.
Wydane: (2010)

Oxali(IV)Fluors: fluorescence responsive oxaliplatin(IV) complexes identify a hypoxia-dependent reduction in cancer cells
od: Boulet, M, i wsp.
Wydane: (2023)

Hypoxia and oxidative stress in breast cancer. Hypoxia and tumourigenesis
od: Knowles, H, i wsp.
Wydane: (2001)

Hypoxia and oxidative stress in breast cancer. Hypoxia and tumourigenesis.
od: Knowles, H, i wsp.
Wydane: (2001)

An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3.
od: Ramachandran, A, i wsp.
Wydane: (2013)

An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3
od: Ramachandran, A, i wsp.
Wydane: (2013)

Aps: an itinerary for competences in the subject of adapted sport
od: José Manuel Puchalt Hernández
Wydane: (2020-06-01)

In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer
od: Basel Abu-Jamous, i wsp.
Wydane: (2017-06-01)

Regulation of autophagy by ATF4 in response to severe hypoxia.
od: Rzymski, T, i wsp.
Wydane: (2010)

Are there specific molecular adaptations of skeletal muscle to repeated sprint training in hypoxia?
od: Clément Lanfranchi, i wsp.
Wydane: (2024-02-01)

Significant molecular and systemic adaptations after repeated sprint training in hypoxia.
od: Raphael Faiss, i wsp.
Wydane: (2013-01-01)

Anti-apoptotic role of HIF-1 and AP-1 in paclitaxel exposed breast cancer cells under hypoxia
od: Raes Martine, i wsp.
Wydane: (2010-07-01)

Adaptation of mammals to hypoxia
od: Fang Li, i wsp.
Wydane: (2021-12-01)

Survival Pathways of HIF-Deficient Tumour Cells: TCA Inhibition, Peroxisomal Fatty Acid Oxidation Activation and an AMPK-PGC-1α Hypoxia Sensor
od: Monika A. Golinska, i wsp.
Wydane: (2022-11-01)

Prediction of immunotherapy efficacy and immunomodulatory role of hypoxia in colorectal cancer
od: Zhuangzhuang Zheng, i wsp.
Wydane: (2022-11-01)

Links between the unfolded protein response and the DNA damage response in hypoxia: a systematic review
od: Bolland, H, i wsp.
Wydane: (2021)

Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene (British Journal of Cancer (2010) 102 (428435) DOI:10.1038/sj.bjc.6605450))
od: Buffa, F, i wsp.
Wydane: (2010)

Proline-hydroxylated hypoxia-inducible factor 1α (HIF-1α) upregulation in human tumours.
od: Cameron E Snell, i wsp.
Wydane: (2014-01-01)

A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer.
od: Eustace, A, i wsp.
Wydane: (2013)